Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Sirolimus and Cyclosporine With Post-Transplant Cyclophosphamide or Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis in Unrelated Donor Hematopoietic Cell Transplantation.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 03, 2025
Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Clinical and Humoral Risk Factors for Infection.
Journal: Open forum infectious diseases
Published: August 27, 2025
Diagnostic Yield of Repeat Blood Cultures and Risk Factors for Bloodstream Infection in Persistent Febrile Neutropenia.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: July 25, 2025
Donor-derived del[20q] following allogeneic-hematopoietic cell transplantation: a case with 26-year follow-up and literature review.
Journal: Bone marrow transplantation
Published: July 22, 2025
ELISPOT as a predictor of clinically significant cytomegalovirus infection after hematopoietic cell transplantation in letermovir recipients.
Journal: Bone marrow transplantation
Published: February 04, 2025
Correction: Novel factors to predict respiratory viral disease progression in allogeneic hematopoietic cell transplant recipients.
Journal: Bone marrow transplantation
Published: October 11, 2024
COVID-19 Outcomes Among Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Recipients in the Era of SARS-CoV-2 Omicron Variants and COVID-19 Therapeutics.
Journal: Transplantation and cellular therapy
Published: June 12, 2024
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 12, 2024
Decreasing chronic graft-versus-host disease rates in all populations.
Journal: Blood advances
Published: January 22, 2024
Flow cytometry of DNMT1 as a biomarker of hypomethylating therapies.
Journal: Cytometry. Part B, Clinical cytometry
Published: November 22, 2023
Last Updated: 09/26/2026